medigraphic.com
SPANISH

Revista Médica de Costa Rica y Centroamérica

Colegio de Medicos y Cirujanos República de Costa Rica
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 611

<< Back Next >>

Rev Med Cos Cen 2014; 71 (611)

Bacteriemia por Staphylococcus aureus en el hospital México 2009

Miranda CM,Elias MS, Villalobos VJ
Full text How to cite this article

Language: Spanish
References: 10
Page: 573-580
PDF size: 270.15 Kb.


Key words:

No keywords

ABSTRACT

Staphylococcus aureus bacteraemia is a serious and highly fatal infection. No published information on this condition in our country, so knowing its characteristics is very important. This is a retrospective, observational, descriptive epidemiological study type, held in Mexico Hospital in 2009 and included 72 patients older than 12 years. The incidence was 2.6 cases per 100 admissions. There was no difference in gender distribution, average age 52 years and 67% of patients had less than 60 years. Most affected (67 % ) suffered from 3 or more associated diseases , the most common: chronic renal failure ( 42 % ), diabetes mellitus ( 35 % ) , heart disease ( 24%) and malignancies ( 18%). Risk factors included central venous catheter (36%), dialysis (36%) and surgery in the previous 30 days (26%). The third part acquired the infection in the community, the rest of the cases relate to health care. Methicillin -resistant S. aureus (MRSA ) was responsible for 58 % of episodes of bacteremia . About half of the patients had severe forms of infection such as severe sepsis and septic shock. 60% of episodes of MRSA bacteremia received inappropriate initial treatment but 85 % was treated with an appropriate scheme available once the antibiogram. This did not occur in cases of MSSA bacteraemia where most deal with a useful scheme. Patients treated with inappropriate initial scheme had a high mortality and most died in the first 6 days of bacteremia. Other sites simultaneously S. aureus infections were present in 42% of cases. Mortality at 30 days of bacteremia was 39 % but the risk of dying from this condition was significantly greater when treatment was inadequate or the patient was over 60 years.


REFERENCES

  1. Baba T, Takeuchi T, Kuroda M,Yuzawa, Aoki k, Oguchi A, Nagai Y, Iwama N, Asano K, Naimi T (2002).Inglaterra,Genome and virulence determinants of high virulence community-acquired MRSA. The Lancet. Volumen 359.

  2. Deresinski S. (2005), Estados Unidos de América Methicillinresistant Staphylococcus aureus: An evolutionary, epidemiologic and therapeutic odyssey. Clin Infect Dis.

  3. Harrison Principios de Medicina Interna 16a edición. Parte VI. Enfermedades infecciosas; Sección 5. Enfermedades causadas por bacterias grampositivas. http://www. harrisonmedicina.com/content.aspx ?aID=69453&searchStr=staphyloco ccus+aureus#6945

  4. Jensen A. (2000), Inglaterra, Treatment of Staphylococcus aureus bacteremia and secondary infections. Antimicrob Infect Dis News.

  5. Lalueza Blanco Antonio. (2008), Madrid, Importancia actual de la Bacteriemia por Staphylococcus aureus en un Hospital Universitario.

  6. Lesens O, Hansmann Y, Brannigan E, and Hopkins S, Meyer P, OConnel B, et al. (2005), Estados Unidos de America, Healthcare-associated Staphylococcus aureus bacteremia and the risk for methicillin resistance: is the Centers for Disease control and Prevention definition for community acquired bacteremia still appropriate? Infect Control Hosp Epidemiol.

  7. Lesens O, Hansmann Y, Storck D, Christmann D.(2003), España Risk factors for metastatic infection in patients with Staphylococcus aureus bacteremia with and without endocarditis. Eur J Intern Med.

  8. Lodise T, McKinnon P.(2005) Estados Unidos de América, Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia. Diagn Microbiol Infect Dis.

  9. Lowy Franklin D, M.D (1998). Staphylococcus aureus infections. N Engl J Med 339:520, 1998 [PMID: 9709046]. Recuperado el 7 junio del 2010 de http://content.nejm.org/cgi/ content/full/339/8/520?ijkey=816d8 2e9f1592c940095c3fa08c2dd6fee48 22c0&keytype2=tf_ipsecsha

  10. Von Eiff C, Peters G, Heilmann C (2002);Estados Unidos de América, Pathogenesis of infections due to coagulase-negative staphylococci. voLancet Infect Dis.[Medline]




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med Cos Cen. 2014;71